CRISPR Therapeutics AG Current Ratio 2015-2020 | CRSP

CRISPR Therapeutics AG current ratio from 2015 to 2020. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
CRISPR Therapeutics AG Current Ratio Historical Data
Date Current Assets Current Liabilities Current Ratio
2020-03-31 $0.93B $0.06B 16.87
2019-12-31 $0.99B $0.06B 17.29
2019-09-30 $0.66B $0.08B 8.32
2019-06-30 $0.44B $0.03B 13.96
2019-03-31 $0.45B $0.03B 15.84
2018-12-31 $0.47B $0.03B 16.81
2018-09-30 $0.50B $0.03B 15.39
2018-06-30 $0.33B $0.02B 17.89
2018-03-31 $0.35B $0.01B 24.42
2017-12-31 $0.25B $0.02B 17.12
2017-09-30 $0.26B $0.01B 21.34
2017-06-30 $0.28B $0.02B 17.79
2017-03-31 $0.30B $0.02B 17.53
2016-12-31 $0.32B $0.02B 14.56
2016-09-30 $0.23B $0.08B 2.97
2016-06-30 $0.25B $0.08B 3.09
2016-03-31 $0.00B 0.00
2015-12-31 $0.00B 0.00
2015-09-30 $0.00B 0.00
2014-12-31 $0.00B $0.00B 0.45
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $3.802B $0.290B
CRISPR Therapeutics AG is a gene-editing company. It focused on the development of transformative gene-based medicines for serious diseases using its proprietary CRISPR/Cas9 gene-editing platform. CRISPR Therapeutics AG is headquartered in Basel, Switzerland.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $131.844B 14.52
Gilead Sciences (GILD) United States $94.479B 12.25
CSL (CSLLY) Australia $86.864B 0.00
Vertex Pharmaceuticals (VRTX) United States $71.918B 49.44
Regeneron Pharmaceuticals (REGN) United States $63.614B 24.52
Illumina (ILMN) United States $54.832B 56.35
Biogen (BIIB) United States $49.038B 8.39
Seattle Genetics (SGEN) United States $26.234B 0.00
Alexion Pharmaceuticals (ALXN) United States $25.267B 10.86
Incyte (INCY) United States $21.857B 0.00
Moderna (MRNA) United States $20.618B 0.00
Genmab (GMAB) Denmark $20.217B 16.65
Genmab (GNMSF) Denmark $19.174B 56.92
BioMarin Pharmaceutical (BMRN) United States $19.096B 173.12
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $18.127B 0.00
Alnylam Pharmaceuticals (ALNY) United States $15.282B 0.00
Bio-Rad Laboratories (BIO.B) United States $13.825B 62.93
Galapagos (GLPG) Belgium $13.059B 38.67
Exact Sciences (EXAS) United States $12.562B 0.00
BeiGene (BGNE) Cayman Islands $12.557B 0.00
Sarepta Therapeutics (SRPT) United States $11.932B 0.00
BioNTech SE (BNTX) Germany $10.605B 0.00
QIAGEN (QGEN) Netherlands $9.894B 28.77
Bio-Techne Corp (TECH) United States $9.877B 65.25
Horizon Therapeutics Public (HZNP) Ireland $9.300B 22.89
ARGENX SE-ADR (ARGX) Netherlands $9.058B 0.00
Guardant Health (GH) United States $8.309B 0.00
ACADIA Pharmaceuticals (ACAD) United States $7.901B 0.00
Immunomedics (IMMU) United States $7.689B 0.00
Exelixis (EXEL) United States $7.461B 26.16
Ascendis Pharma (ASND) Denmark $7.044B 0.00
Repligen (RGEN) United States $6.758B 118.54
Acceleron Pharma (XLRN) United States $5.330B 0.00
Adaptive Biotechnologies (ADPT) United States $4.938B 0.00
Reata Pharmaceuticals (RETA) United States $4.894B 0.00
MyoKardia (MYOK) United States $4.675B 0.00
Mirati Therapeutics (MRTX) United States $4.495B 0.00
China Biologic Products (CBPO) China $4.335B 24.10
Emergent Biosolutions (EBS) United States $4.298B 28.17
MorphoSys AG (MOR) Germany $4.234B 32.84
Global Blood Therapeutics (GBT) United States $4.190B 0.00
Ultragenyx Pharmaceutical (RARE) United States $4.092B 0.00
Zai Lab (ZLAB) China $3.972B 0.00
Momenta Pharmaceuticals (MNTA) United States $3.733B 0.00
Vir Biotechnology (VIR) United States $3.721B 0.00
Blueprint Medicines (BPMC) United States $3.630B 0.00
Bluebird Bio (BLUE) United States $3.384B 0.00
Halozyme Therapeutics (HALO) United States $3.186B 0.00
Deciphera Pharmaceuticals (DCPH) United States $3.184B 0.00
Amicus Therapeutics (FOLD) United States $3.141B 0.00
NeoGenomics (NEO) United States $2.914B 212.77
Denali Therapeutics (DNLI) United States $2.896B 0.00
Arena Pharmaceuticals (ARNA) United States $2.806B 0.00
UniQure (QURE) Netherlands $2.793B 0.00
Alkermes (ALKS) Ireland $2.646B 52.09
Amarin (AMRN) Ireland $2.633B 0.00
Novavax (NVAX) United States $2.599B 0.00
Insmed (INSM) United States $2.521B 0.00
Fate Therapeutics (FATE) United States $2.503B 0.00
Alector (ALEC) United States $2.487B 0.00
Intercept Pharmaceuticals (ICPT) United States $2.396B 0.00
Viela Bio (VIE) United States $2.327B 0.00
Principia Biopharma (PRNB) United States $2.126B 0.00
Inovio Pharmaceuticals (INO) United States $2.111B 0.00
Eidos Therapeutics (EIDX) United States $1.862B 0.00
Epizyme (EPZM) United States $1.861B 0.00
Arvinas (ARVN) United States $1.756B 0.00
Zymeworks (ZYME) Canada $1.702B 0.00
Adverum Biotechnologies (ADVM) United States $1.625B 0.00
Ligand Pharmaceuticals (LGND) United States $1.618B 62.99
Sangamo Therapeutics (SGMO) United States $1.612B 0.00
Dicerna Pharmaceuticals (DRNA) United States $1.546B 0.00
Akcea Therapeutics (AKCA) United States $1.526B 0.00
Editas Medicine (EDIT) United States $1.501B 0.00
REGENXBIO (RGNX) United States $1.484B 0.00
Mesoblast (MESO) Australia $1.469B 0.00
Twist Bioscience (TWST) United States $1.468B 0.00
PHARMA MAR SA (PHMMF) Spain $1.405B 0.00
Intra-Cellular Therapies (ITCI) United States $1.397B 0.00
NGM Biopharmaceuticals (NGM) United States $1.390B 0.00
I-Mab (IMAB) China $1.389B 0.00
Zealand Pharma (ZEAL) Denmark $1.366B 0.00
Arcus Biosciences (RCUS) United States $1.299B 0.00
Coherus BioSciences (CHRS) United States $1.294B 9.03
Beam Therapeutics (BEAM) United States $1.288B 0.00
Cytokineticsorporated (CYTK) United States $1.232B 0.00
Revance Therapeutics (RVNC) United States $1.216B 0.00
Mersana Therapeutics (MRSN) United States $1.161B 0.00
Myriad Genetics (MYGN) United States $1.074B 55.42
Sorrento Therapeutics (SRNE) United States $1.038B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $0.933B 0.00
Pharming Group (PHGUF) Netherlands $0.933B 0.00
NextCure (NXTC) United States $0.914B 0.00
Orchard Therapeutics (ORTX) United Kingdom $0.911B 0.00
Athenex (ATNX) United States $0.908B 0.00
Intellia Therapeutics (NTLA) United States $0.900B 0.00
Compugen (CGEN) Israel $0.847B 0.00
Heska (HSKA) United States $0.813B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $0.806B 0.00
Cue Biopharma (CUE) United States $0.774B 0.00
Cellectis S.A (CLLS) France $0.769B 0.00
Cara Therapeutics (CARA) United States $0.760B 0.00
Codexis (CDXS) United States $0.744B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.732B 0.00
Alcobra (ARCT) United States $0.731B 0.00
Kadmon Holdings (KDMN) United States $0.714B 0.00
Retrophin (RTRX) United States $0.692B 0.00
Kala Pharmaceuticals (KALA) United States $0.669B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.658B 0.00
Castle Biosciences (CSTL) United States $0.657B 0.00
NantKwest (NK) United States $0.651B 0.00
Morphic Holding (MORF) United States $0.645B 0.00
Vericel (VCEL) United States $0.642B 118.58
Adaptimmune Therapeutics (ADAP) United Kingdom $0.632B 0.00
Stemline Therapeutics (STML) United States $0.623B 0.00
Bellus Health (BLU) Canada $0.622B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.603B 5.16
Syndax Pharmaceuticals (SNDX) United States $0.579B 0.00
MeiraGTx Holdings (MGTX) United States $0.562B 0.00
Frequency Therapeutics (FREQ) United States $0.561B 0.00
Athersys (ATHX) United States $0.546B 0.00
Scholar Rock Holding (SRRK) United States $0.543B 0.00
Clovis Oncology (CLVS) United States $0.542B 0.00
DBV Technologies S.A (DBVT) France $0.535B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.533B 0.00
AnaptysBio (ANAB) United States $0.525B 0.00
AC Immune SA (ACIU) Switzerland $0.516B 0.00
UROGEN PHARMA (URGN) United States $0.502B 0.00
Anika Therapeutics (ANIK) United States $0.485B 15.61
Agenus (AGEN) United States $0.482B 0.00
BioDelivery Sciences (BDSI) United States $0.479B 25.21
Aquinox Pharmaceuticals (NLTX) United States $0.464B 0.00
VBI Vaccines (VBIV) United States $0.457B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.455B 0.00
Cel-Sci (CVM) United States $0.455B 0.00
Protagonist Therapeutics (PTGX) United States $0.454B 0.00
Dynavax Technologies (DVAX) United States $0.446B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.444B 0.00
Prothena (PRTA) Ireland $0.443B 0.00
Syros Pharmaceuticals (SYRS) United States $0.435B 0.00
Puma Biotechnology (PBYI) United States $0.426B 0.00
Merus (MRUS) Netherlands $0.411B 0.00
Albireo Pharma (ALBO) United States $0.405B 0.00
Seres Therapeutics (MCRB) United States $0.402B 0.00
MiMedx (MDXG) United States $0.401B 0.00
CytomX Therapeutics (CTMX) United States $0.401B 0.00
Intrexon (PGEN) United States $0.400B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.397B 0.00
ANI Pharmaceuticals (ANIP) United States $0.385B 7.62
PDL BioPharma (PDLI) United States $0.382B 328.00
Precision BioSciences (DTIL) United States $0.366B 0.00
WAVE Life Sciences (WVE) Singapore $0.358B 0.00
Menlo Therapeutics (MNLO) United States $0.342B 0.00
Kamada (KMDA) Israel $0.341B 14.20
Geron (GERN) United States $0.323B 0.00
Selecta Biosciences (SELB) United States $0.322B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.321B 0.00
Avid Bioservices (CDMO) United States $0.319B 0.00
MannKind (MNKD) United States $0.318B 0.00
OSMOTICA PHARM (OSMT) United States $0.306B 0.00
ChromaDex (CDXC) United States $0.293B 0.00
Verastem (VSTM) United States $0.286B 0.00
Starpharma Holdings (SPHRY) Australia $0.281B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.274B 0.00
Abeona Therapeutics (ABEO) United States $0.271B 0.00
Liquidia Technologies (LQDA) United States $0.269B 0.00
Cellular Biomedicine (CBMG) United States $0.268B 0.00
Aduro Biotech (ADRO) United States $0.264B 0.00
ADMA Biologics Inc (ADMA) United States $0.247B 0.00
Gritstone Oncology (GRTS) United States $0.245B 0.00
Spero Therapeutics (SPRO) United States $0.244B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.242B 0.00
Fortress Biotech (FBIO) United States $0.242B 0.00
Northwest Biotherapeutics (NWBO) United States $0.239B 0.00
Affimed (AFMD) Germany $0.238B 0.00
HOOKIPA Pharma (HOOK) United States $0.237B 0.00
Pfenex (PFNX) United States $0.235B 0.00
XOMA (XOMA) United States $0.234B 0.00
Exicure (XCUR) United States $0.233B 0.00
Sutro Biopharma (STRO) United States $0.223B 0.00
POXEL SA FRANCE (PXXLF) France $0.219B 0.00
Prometic Life Sciences (LMNL) Canada $0.218B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.217B 3.27
Pluristem Therapeutics (PSTI) Israel $0.207B 0.00
GENFIT S.A (GNFT) France $0.201B 0.00
IVERIC Bio (ISEE) United States $0.198B 0.00
ARAVIVE, INC (ARAV) United States $0.195B 0.00
VTv Therapeutics (VTVT) United States $0.195B 0.00
Strongbridge Biopharma (SBBP) United States $0.194B 0.00
IBio (IBIO) United States $0.189B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.185B 0.00
Five Prime Therapeutics (FPRX) United States $0.184B 0.00
Aptinyx (APTX) United States $0.179B 0.00
Cerecor (CERC) United States $0.174B 0.00
PHASEBIO PHARMA (PHAS) United States $0.173B 0.00
Kindred Biosciences (KIN) United States $0.173B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.168B 0.00
Aytu Bioscience (AYTU) United States $0.168B 0.00
Dyadic (DYAI) United States $0.166B 0.00
Newron Pharmaceuticals SpA (NWPHF) Italy $0.159B 0.00
Antibe Therapeutics (ATBPF) Canada $0.158B 0.00
TELA Bio (TELA) United States $0.156B 0.00
Theratechnologies (THTX) Canada $0.155B 0.00
Celyad SA (CYAD) Belgium $0.153B 0.00
Orgenesis (ORGS) United States $0.151B 0.00
Arbutus Biopharma (ABUS) Canada $0.149B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.148B 0.00
Biofrontera AG (BFRA) Germany $0.146B 0.00
Cidara Therapeutics (CDTX) United States $0.146B 0.00
Trevena (TRVN) United States $0.141B 0.00
Lineage Cell Therapeutics (LCTX) United States $0.139B 0.00
Enzo Biochem (ENZ) United States $0.137B 0.00
VolitionRX (VNRX) United States $0.127B 0.00
Applied Genetic Technologies (AGTC) United States $0.124B 0.00
Checkpoint Therapeutics (CKPT) United States $0.122B 0.00
CorMedix Inc (CRMD) United States $0.120B 0.00
Lumos Pharma (LUMO) United States $0.120B 0.00
Palatin Technologies (PTN) United States $0.120B 3.07
AIT Therapeutics (XAIR) United States $0.116B 0.00
Protalix BioTherapeutics (PLX) Israel $0.115B 0.00
Cyclerion Therapeutics (CYCN) United States $0.112B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.110B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.106B 0.00
Windtree Therapeutics (WINT) United States $0.100B 0.00
Eton Pharmaceuticals (ETON) United States $0.096B 0.00
Oncobiologics (OTLK) United States $0.092B 0.00
Catalyst Biosciences (CBIO) United States $0.089B 0.00
SESEN BIO, INC (SESN) United States $0.088B 0.00
AquaBounty Technologies (AQB) United States $0.087B 0.00
Organovo Holdings (ONVO) United States $0.087B 0.00
Celsion (CLSN) United States $0.086B 0.00
AnPac Bio-Medical Science (ANPC) China $0.085B 0.00
Clearside Biomedical (CLSD) United States $0.085B 0.00
Synlogic (SYBX) United States $0.080B 0.00
Stealth BioTherapeutics (MITO) United States $0.070B 0.00
Proteostasis Therapeutics (PTI) United States $0.068B 0.00
Emmaus Life Sciences (EMMA) United States $0.067B 0.00
Happiness Biotech Group (HAPP) China $0.066B 0.00
DiaMedica Therapeutics (DMAC) United States $0.065B 0.00
Vaccinex (VCNX) United States $0.062B 0.00
Signal Genetics (MGEN) United States $0.061B 0.00
Idera Pharmaceuticals (IDRA) United States $0.059B 0.00
Ecology Coatings (ABVC) United States $0.057B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.057B 0.00
Apricus Biosciences (SEEL) United States $0.057B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.056B 0.00
CollPlant Holdings (CLGN) Israel $0.056B 0.00
Soligenix (SNGX) United States $0.054B 0.00
Vascular Biogenics (VBLT) Israel $0.052B 0.00
Cocrystal Pharma (COCP) United States $0.050B 0.00
Celldex Therapeutics (CLDX) United States $0.050B 0.00
Prima BioMed (IMMP) Australia $0.049B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.048B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.046B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.044B 0.00
Pulmatrix (PULM) United States $0.043B 0.00
Advaxis (ADXS) United States $0.042B 0.00
AmpliPhi Biosciences (ARMP) United States $0.042B 0.00
Cesca Therapeutics (THMO) United States $0.040B 0.00
Chanticleer Holdings (SONN) United States $0.039B 0.00
OvaScience (MLND) United States $0.038B 0.00
Acorda Therapeutics (ACOR) United States $0.037B 0.00
ATyr Pharma (LIFE) United States $0.035B 0.00
TOCAGEN INC (TOCA) United States $0.031B 0.00
TrovaGene (CRDF) United States $0.031B 0.00
Curis (CRIS) United States $0.031B 0.00
BioCardia (BCDA) United States $0.028B 0.00
Stellar Biotechnologies (EDSA) Canada $0.028B 0.00
Titan Pharmaceuticals (TTNP) United States $0.027B 0.00
AEterna Zentaris (AEZS) United States $0.027B 0.00
Evogene (EVGN) Israel $0.027B 0.00
Alimera Sciences (ALIM) United States $0.026B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.026B 0.00
Spherix (AIKI) United States $0.026B 0.00
Entera Bio (ENTX) Israel $0.023B 0.00
Cleveland BioLabs (CBLI) United States $0.022B 0.00
PLANET GREEN HOLDINGS CORP (PLAG) China $0.021B 0.00
VIVUS (VVUS) United States $0.021B 0.00
Novogen (KZIA) Australia $0.020B 0.00
Aptevo Therapeutics (APVO) United States $0.019B 0.00
Unum Therapeutics (UMRX) United States $0.019B 0.00
Genetic Technologies (GENE) Australia $0.017B 0.00
Bionano Genomics (BNGO) United States $0.017B 0.00
TRACON Pharmaceuticals (TCON) United States $0.012B 0.00
MYOS RENS Technology (MYOS) United States $0.010B 0.00
Neuralstem (SNCA) United States $0.009B 0.00
Prana Biotechnology (ATHE) Australia $0.009B 0.00
Benitec Biopharma (BNTC) Australia $0.008B 0.00
IMMURON (IMRN) Australia $0.008B 0.00
BioPharmX (TMBR) United States $0.004B 0.00
Sinovac Biotech (SVA) China $0.001B 0.03
Innate Pharma S.A (IPHA) France $0.000B 0.00